As a single factor, the presence of NUP98-NSD1 in AML blasts of patients at diagnosis was associated with a significant increase in CIR (81%) in addition to decreased probabilities of 3-year EFS and OS (Figure 4(a)). Here, NSD1 is linked to acute myeloid leukemia.